Literature DB >> 27903817

Effects of orthostatic hypotension on cognition in Parkinson disease.

Justin Centi1, Roy Freeman1, Christopher H Gibbons1, Sandy Neargarder1, Alexander O Canova1, Alice Cronin-Golomb2.   

Abstract

OBJECTIVE: To investigate the relation between orthostatic hypotension (OH) and posture-mediated cognitive impairment in Parkinson disease (PD) using a cross-sectional and within-group design.
METHODS: Individuals without dementia with idiopathic PD included 18 with OH (PDOH) and 19 without OH; 18 control participants were also included. Neuropsychological tests were conducted in supine and upright-tilted positions. Blood pressure was assessed in each posture.
RESULTS: The PD groups performed similarly while supine, demonstrating executive dysfunction in sustained attention and response inhibition, and reduced semantic fluency and verbal memory (encoding and retention). Upright posture exacerbated and broadened these deficits in the PDOH group to include phonemic fluency, psychomotor speed, and auditory working memory. When group-specific supine scores were used as baseline anchors, both PD groups showed cognitive changes following tilt, with the PDOH group exhibiting a wider range of deficits in executive function and memory as well as significant changes in visuospatial function.
CONCLUSIONS: Cognitive deficits in PD have been widely reported with assessments performed in the supine position, as seen in both our PD groups. Here we demonstrated that those with PDOH had transient, posture-mediated changes in excess of those found in PD without OH. These observed changes suggest an acute, reversible effect. Understanding the effects of OH due to autonomic failure on cognition is desirable, particularly as neuroimaging and clinical assessments collect data only in the supine or seated positions. Identification of a distinct neuropsychological profile in PD with OH has quality of life implications, and OH presents itself as a possible target for intervention in cognitive disturbance.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27903817      PMCID: PMC5200856          DOI: 10.1212/WNL.0000000000003452

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

1.  Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Neurology       Date:  2015-09-23       Impact factor: 9.910

Review 2.  Test review: Delis-Kaplan executive function system.

Authors:  Susan Homack; Donghyung Lee; Cynthia A Riccio
Journal:  J Clin Exp Neuropsychol       Date:  2005-07       Impact factor: 2.475

3.  Coevolution of white matter hyperintensities and cognition in the elderly.

Authors:  Pauline Maillard; Owen Carmichael; Evan Fletcher; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

Review 4.  Orbital and ventromedial prefrontal cortex functioning in Parkinson's disease: neuropsychological evidence.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  Brain Cogn       Date:  2012-03-03       Impact factor: 2.310

5.  Prevalence of orthostatic hypotension in Parkinson's disease.

Authors:  J M Senard; S Raï; M Lapeyre-Mestre; C Brefel; O Rascol; A Rascol; J L Montastruc
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

6.  Impact of optic flow perception and egocentric coordinates on veering in Parkinson's disease.

Authors:  Sigurros Davidsdottir; Robert Wagenaar; Daniel Young; Alice Cronin-Golomb
Journal:  Brain       Date:  2008-10-28       Impact factor: 13.501

Review 7.  Dysautonomia in Parkinson's disease: neurocardiological abnormalities.

Authors:  David S Goldstein
Journal:  Lancet Neurol       Date:  2003-11       Impact factor: 44.182

8.  Measuring premorbid IQ in traumatic brain injury: an examination of the validity of the Wechsler Test of Adult Reading (WTAR).

Authors:  Robin E A Green; Brenda Melo; Bruce Christensen; Le-Anh Ngo; Georges Monette; Cheryl Bradbury
Journal:  J Clin Exp Neuropsychol       Date:  2008-02       Impact factor: 2.475

9.  Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.

Authors:  Pekka Jokinen; Mira Karrasch; Anna Brück; Jarkko Johansson; Jörgen Bergman; Juha O Rinne
Journal:  J Neurol Sci       Date:  2013-04-03       Impact factor: 3.181

10.  Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study.

Authors:  Yoichi Sawada; Yoshiyuki Nishio; Kyoko Suzuki; Kazumi Hirayama; Atsushi Takeda; Yoshiyuki Hosokai; Toshiyuki Ishioka; Yasuto Itoyama; Shoki Takahashi; Hiroshi Fukuda; Etsuro Mori
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

View more
  23 in total

1.  Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.

Authors:  Michela Sforza; Francesca Assogna; Domiziana Rinaldi; Giuliano Sette; Stefania Tagliente; Francesco E Pontieri
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

2.  Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.

Authors:  Srikanth Muppidi; Mitchell G Miglis
Journal:  Clin Auton Res       Date:  2017-03-02       Impact factor: 4.435

3.  Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Authors:  Juan Francisco Idiaquez; Juan Idiaquez; Juan Carlos Casar; Italo Biaggioni
Journal:  Am J Hypertens       Date:  2021-03-11       Impact factor: 2.689

4.  Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

Review 5.  Management of Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Continuum (Minneap Minn)       Date:  2020-02

Review 6.  New evidence on the management of Lewy body dementia.

Authors:  John-Paul Taylor; Ian G McKeith; David J Burn; Brad F Boeve; Daniel Weintraub; Claire Bamford; Louise M Allan; Alan J Thomas; John T O'Brien
Journal:  Lancet Neurol       Date:  2019-09-10       Impact factor: 44.182

Review 7.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

Review 8.  Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.

Authors:  Cyndya A Shibao; Horacio Kaufmann
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 9.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

10.  Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease.

Authors:  Bryan A Bernard; Danielle Carns; Glenn T Stebbins; Jennifer G Goldman; Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2020-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.